1192569-38-2 Usage
General Description
2-Chloro-5-quinolinecarboxylic acid methyl ester, also known as chloroquine methyl ester, is a chemical compound with potential pharmaceutical applications. It is a derivative of chloroquine, an antimalarial medication used to treat and prevent malaria. 2-Chloro-5-quinolinecarboxylic acid methyl ester is a methyl ester of 2-chloro-5-quinolinecarboxylic acid, and it has been studied for its potential anti-inflammatory and antiviral properties. Additionally, it has been investigated for its potential in cancer treatment and as a therapeutic tool for autoimmune diseases. Its structure and properties make it an interesting molecule for further research in the fields of medicine and pharmacology.
Check Digit Verification of cas no
The CAS Registry Mumber 1192569-38-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,2,5,6 and 9 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1192569-38:
(9*1)+(8*1)+(7*9)+(6*2)+(5*5)+(4*6)+(3*9)+(2*3)+(1*8)=182
182 % 10 = 2
So 1192569-38-2 is a valid CAS Registry Number.
1192569-38-2Relevant articles and documents
INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS
-
, (2022/02/05)
Provided herein are compounds of formula (V) that bind to BF3 of an androgen receptor (AR), which can modulate the AR for the treatment of Kennedy's disease.
BENZOTHIOPHENE DERIVATIVE
-
, (2016/02/18)
[Problem to be Solved] It is intended to provide a compound having PDE10A inhibitory activity and having a novel structure, or an isotope thereof or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same as an active ingredient. [Solution] The present invention provides a compound represented by the general formula (I) or a pharmaceutically acceptable salt thereof.
QUINOLINE OR ISOQUINOLINE SUBSTITUTED P2X7 ANTAGONISTS
-
Page/Page column 22, (2009/12/05)
The present invention is related to novel compounds of formula (I) having P2X7 antagonistic properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment or prophylaxis of diseases associated with P2X7 receptor activity in animals, in particular humans. (I)
